Commvault is adding features to protect data from quantum-based exploits, which is especially relevant in sectors such as ...

The coming years are likely to see a fusion of innovation and individual empowerment reshaping how people secure their ...

Organizations are experiencing accelerated digital transformation driven by AI and cloud adoption, leaving CISOs with a stark ...

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data. Written by Lance Whitney, Contributor May 19 ...

Enterprise data management (EDM) is the framework organizations use to manage data across systems, teams and workflows. It ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from ...

Your DNA results are in — and they're 100 percent the property of a pharmaceutical manufacturer. American biotech company Regeneron Pharmaceuticals announced today that it's buying 23andMe, the ...

The new Encrypted Guardrails for Operational Security combines DataKrypto’s real-time encryption of retrieval-augmented ...

In a bold move to redefine the future of human performance and wellbeing, MAXIOM Labs and DNAthlete AG today announced a strategic partnership to combine ...

Regeneron is buying 23andMe for $256M in bankruptcy, gaining access to DNA data from 15 million users to aid drug research.

Bankruptcy left DNA testing outlet 23andMe looking for a buyer for its data. But as a philosophy professor notes, it shouldn’t have the constitutional right to do so.